Cargando…
Galectin‐3 in venous thrombosis: A possible new target for improved patient care
Autores principales: | Flaherty, Melanie M., Palmer, Olivia R., Diaz, Jose A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055560/ https://www.ncbi.nlm.nih.gov/pubmed/30046744 http://dx.doi.org/10.1002/rth2.12087 |
Ejemplares similares
-
SARS-CoV-2 infection: possible underdiagnosis of cerebral venous sinus thrombosis()
por: Almarcha-Menargues, M.L., et al.
Publicado: (2021) -
eThrombosis: A new risk factor for venous thromboembolism in the pandemic era
por: Sueta, Daisuke, et al.
Publicado: (2020) -
Improving Care of Older Patients with Hemophilia During COVID-19 Pandemic, Reducing the Risk of Venous Thrombosis with Home Exercises
por: Demirci, Ufuk, et al.
Publicado: (2022) -
Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis
por: Marchandot, Benjamin, et al.
Publicado: (2021) -
Malignant Cerebral Venous Sinus Thrombosis in Polycythemia
por: Mahale, Rohan, et al.
Publicado: (2015)